Contagion® is the go-to news resource for practitioners and specialists working in infectious disease.
Get the content you want anytime you want.
REGISTER NOW | SIGN IN
Like Us On Facebook
Follow Us On Twitter
Check us out on LinkedIn
Subscribe us on YouTube
CONFERENCES
OUTBREAK MONITOR
VIDEOS
PUBLICATION
PEER EXCHANGE
INSIGHTS
SEARCH

Contagion Peer Exchange

A unique opportunity to view lively discussions featuring peer-to-peer exchanges that provide authoritative insights, opinions, and perspectives on important issues facing today's infectious disease professionals

Select Topic:
Browse by Series:
Select Year:

Battling Against Resistant Pseudomonas Infections in the ICU

<i>Pseudomonas</i> Infections in the ICU: Who's Susceptible?
Pseudomonas Infections in the ICU: Who's Susceptible?
<i>Pseudomonas</i> Infections: Matching Causes and Prevention
Pseudomonas Infections: Matching Causes and Prevention
<i>Pseudomonas</i> Infections in the ICU Versus on the Floor
Pseudomonas Infections in the ICU Versus on the Floor
<i>Pseudomonas</i> Infections: Nuancing the Use of Antibiotics
Pseudomonas Infections: Nuancing the Use of Antibiotics
Fighting <i>Pseudomonas</i>: Impact On Patient Prognosis & Approaches to Combat Infection
Fighting Pseudomonas: Impact On Patient Prognosis & Approaches to Combat Infection
Classes and Agents Available to Treat <i>Pseudomonas</i> Infections
Classes and Agents Available to Treat Pseudomonas Infections
<i>Pseudomonas</i> Infections Continue to Acquire Resistance, Complicating Treatment
Pseudomonas Infections Continue to Acquire Resistance, Complicating Treatment
Exploring Cephalosporin/β-Lactamase Inhibitor Combinations for Treatment of <i>Pseudomonas</i>
Exploring Cephalosporin/β-Lactamase Inhibitor Combinations for Treatment of Pseudomonas
Exploring Appropriate Treatment Protocols for <i>Pseudomonas</i> Infections
Exploring Appropriate Treatment Protocols for Pseudomonas Infections
Core Challenges in <i>Pseudomonas</i> Treatment Protocol
Core Challenges in Pseudomonas Treatment Protocol
<i>Pseudomonas</i> Infections: Optimizing Diagnostic Strategies
Pseudomonas Infections: Optimizing Diagnostic Strategies
Pseudomonas Infections: Selecting Upfront Antibiotics
Pseudomonas Infections: Selecting Upfront Antibiotics
<i>Pseudomonas</i> Infections: Secondary Approach to Treatment
Pseudomonas Infections: Secondary Approach to Treatment
Treating <i>Pseudomonas</i> Infections With Zerbaxa or Avycaz
Treating Pseudomonas Infections With Zerbaxa or Avycaz
Zerbaxa and Avycaz: Considerations for Treatment
Zerbaxa and Avycaz: Considerations for Treatment
The Future Treatment of Pseudomonas Infections
The Future Treatment of Pseudomonas Infections
FEATURED
A Cure for HIV? An Update One Year Later
A Cure for HIV? An Update One Year Later
Big advances in treatment can't make up for an inability to stop new infections, which number 5,000 per day worldwide.
RELATED SITES
MJH Associates
 
ContagionLive
About Contagion®
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
Like Us On Facebook
Follow Us On Twitter
Check us out on LinkedIn
Subscribe us on YouTube
 
 
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
 
 
About Us | Contact Us | Press Release | Privacy Policy | Terms & Conditions
Copyright© 2006-2018 Intellisphere, LLC. All Rights Reserved.